ClinConnect ClinConnect Logo
Search / Trial NCT04870762

Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

Launched by M.D. ANDERSON CANCER CENTER · Apr 30, 2021

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating a new treatment for patients with head and neck cancers who are undergoing radiation therapy. The study focuses on using customized, 3D-printed oral stents, which are special devices made from a mold of a patient's mouth. These stents cover the teeth and gums during radiation treatment and may help reduce painful mouth blisters and sores that can often occur due to the therapy.

To be eligible for the trial, participants must be 18 years or older and are scheduled to receive 5 to 7 weeks of radiation therapy for their head and neck cancer. They may also receive chemotherapy along with the radiation. Participants will need to sign a consent form to join the study. It's important to note that individuals with a history of head and neck radiation, certain mouth issues, or those who are pregnant or cognitively impaired cannot participate. If you or a loved one meet the eligibility criteria, you may have the opportunity to help improve treatment for others by participating in this trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participant is dispositioned to receive 5-7 weeks of definitive or adjuvant radiotherapy for treatment of a diagnosed head and neck malignancy
  • Age 18 or older
  • ECOG PS 0-2
  • The participant will receive either (a) radiation alone or (b) radiation with concurrent chemotherapy of any kind(s)
  • Signed study-specific consent form
  • Exclusion Criteria:
  • Prior head and neck radiotherapy
  • Participants is unable to fit a tongue-lateralizing or tongue-depressing stent
  • Severe trismus with an incisal opening of \<10 mm
  • Inability to comply with the study procedures
  • Participants younger than 18 years of age
  • Participants must not be pregnant
  • Cognitively impaired subjects

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Houston, Texas, United States

Camden, New Jersey, United States

Jacksonville, Florida, United States

Phoenix, Arizona, United States

Phoenix, Arizona, United States

Indianapolis, Indiana, United States

Indianapolis, Indiana, United States

Indianapolis, Indiana, United States

Patients applied

0 patients applied

Trial Officials

Anna Lee

Principal Investigator

M.D. Anderson Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials